<bill session="114" type="s" number="2188" updated="2023-01-11T13:29:31Z">
  <state datetime="2015-10-21">REFERRED</state>
  <status>
    <introduced datetime="2015-10-21"/>
  </status>
  <introduced datetime="2015-10-21"/>
  <titles>
    <title type="display">Rare Disease Innovation Act</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the humanitarian device exemption.</title>
    <title type="short" as="introduced">Rare Disease Innovation Act</title>
  </titles>
  <sponsor bioguide_id="G000562"/>
  <cosponsors>
    <cosponsor bioguide_id="D000607" joined="2015-10-21"/>
  </cosponsors>
  <actions>
    <action datetime="2015-10-21">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2015-10-21" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="114" type="h" number="2428" relation="unknown"/>
    <bill session="114" type="h" number="6" relation="unknown"/>
    <bill session="114" type="h" number="34" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health technology, devices, supplies"/>
  </subjects>
  <amendments/>
  <summary date="2015-10-28T18:58:21Z" status="Introduced in Senate">Rare Disease Innovation Act

This bill amends the Federal Food, Drug, and Cosmetic Act to expand the humanitarian device exemption to authorize the Food and Drug Administration (FDA) to exempt from effectiveness requirements certain medical devices intended to benefit fewer than 8,000 individuals. Currently, the FDA may exempt devices intended to benefit fewer than 4,000 individuals.

Within 18 months of enactment of this Act, the FDA must define &#8220;probable benefit&#8221; for these devices.

The FDA must report every five years on the effect of this expansion of the humanitarian device exception.</summary>
</bill>
